NCT01667406 - The Use of the Hormone Kisspeptin in 'in Vitro Fertilisation' (IVF) Treatment | Biotech Hunter

Enrollment

175

Participants

Timeline

Start Date

June 1, 2012

Primary Completion Date

October 11, 2016

Study Completion Date

October 11, 2016

Conditions

Infertility

Interventions

DRUG

Kisspeptin 1.6nmol/kg

single kisspeptin dose 1.6 nmol/kg subcutaneously

DRUG

Kisspeptin 3.2nmol/kg

single kisspeptin dose 3.2 nmol/kg subcutaneously

DRUG

Kisspeptin 6.4nmol/kg

single kisspeptin dose 6.4 nmol/kg subcutaneously

DRUG

Kisspeptin 9.6nmol/kg

single kisspeptin dose 9.6 nmol/kg subcutaneously

DRUG

Kisspeptin 12.8nmol/kg

single kisspeptin dose 12.8 nmol/kg subcutaneously

DRUG

Kisspeptin 9.6 nmol/kg double

kisspeptin dose 9.6 nmol/kg given twice 10hrs apart subcutaneously

DRUG

Kisspeptin 9.6 nmol/kg + saline

kisspeptin dose 9.6 nmol/kg subcutaneously and saline subcutaneously, 10hrs apart

Trial Locations (1)

Hammersmith Hospital, London

All Listed Sponsors

lead

Imperial College London

OTHER